Dendritic cell vaccines manufacturing for treatment of cancer patients: a 11-year product quality control test collection of an advanced therapy medicinal product and compliance with the good manufacturing practices guideline.

Saved in:
Bibliographic Details
Title: Dendritic cell vaccines manufacturing for treatment of cancer patients: a 11-year product quality control test collection of an advanced therapy medicinal product and compliance with the good manufacturing practices guideline.
Authors: Granato, A.1 (AUTHOR), Petrini, M.1 (AUTHOR), Pancisi, E.1 (AUTHOR), Piccinini, C.1 (AUTHOR), Soldati, V.1 (AUTHOR), Carloni, S.1 (AUTHOR), Bulgarelli, J.1 (AUTHOR), Tazzari, M.1 (AUTHOR), Ridolfi, L.1 (AUTHOR), De rosa, F.1 (AUTHOR), Guidoboni, M.1 (AUTHOR), Ibrahim, T.1 (AUTHOR)
Source: Cytotherapy (Elsevier Inc.). 2021 Supplement, Vol. 23 Issue 5, pS168-S168. 1p.
Database: Academic Search Ultimate
Description
ISSN:14653249
DOI:10.1016/S1465324921005624